Wednesday, 20 August 2003: 15:45-17:15 | |||
S073 Health Economics and Public Health Implications of Alzheimer's Disease with and without Medical Co-Morbidities | |||
| Although it is well known that the societal costs of Alzheimer´s disease and related dementias (ADRD) are extremely high, it is also obvious that there is a complex interaction between ADRD and comorbid conditions. This fact may be one explanation to the great range in cost of illness studies of dementia. Comorbidity may also act as a confounder in intervention studies (pharmacological as well as non-pharmacological) of ADRD. The effects of comorbidity on the course of ADRD in terms of resource utililization and costs are not sufficiently known and there is a great need for deeper studies in this field. This symposium will present health economical results from Sweden, the USA and Canada where different aspects of ADRD and comorbidity are highlighted. | |||
| Chair: | Anders Wimo | ||
| S073-001 Comorbidity and Costs of Dementia Anders Wimo, Inga Klarin, Britt-Marie Sjolund, Eva I Von Strauss | |||
| S073-002 The Societal Costs of Incident Vascular Cognitive Impairment (VCI) and Alzheimer's Disease in the Canadian Study of Health and Aging Kenneth Rockwood, Chris Skedgel, John D Fisk | |||
| S073-003 Factors Associated with AD Disease Progression (Including Comorbidities) to Nursing Home Placement and Mortality Joel Hay, Danielle Zammit | |||
| S073-004 Cost of Care and Quality of Life in Patients with Alzheimer's Disease in Relation to Comorbidities: Results from a Nordic Study Linus Jönsson, Maria Eriksdotter-Jönhagen, Lena Kilander, Hilkka Soininen, Gunhild Waldemar, Harald Nygaard | |||
| S073-005 Alzheimer's Disease and Related Dementias and Costs of Comorbidities in Managed Medicare Jerrold Hill, Howard Fillit, Robert Futterman, Vera Mastey | |||
Back to The Eleventh International Congress